Identification of a structural determinant necessary for the localization and function of estrogen receptor α at the plasma membrane

Molecular and Cellular Biology

Volumn 23, Issue 5, 2003, Pages 1633-1646

  Razandi, Mahnaz ^a,b   Alton, Gordon ^d   Pedram, Ali ^a,b   Ghonshani, Sanjiv ^a,b   Webb, Paul ^e   Levin, Ellis R ^a,b,c  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CELGENE CORPORATION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; ESTROGEN RECEPTOR ALPHA; LUCIFERASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL MEMBRANE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE DELETION; HORMONE ACTION; HORMONE DETERMINATION; HORMONE STRUCTURE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION;

ANIMALS; BINDING, COMPETITIVE; BREAST NEOPLASMS; CAVEOLIN 1; CAVEOLINS; CELL CYCLE; CELL MEMBRANE; CELL NUCLEUS; CHO CELLS; CRICETINAE; CYCLIN D1; DIMERIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPLASMIC RETICULUM; ESTROGEN RECEPTOR ALPHA; G1 PHASE; GENES, DOMINANT; KINETICS; MICE; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASES; MUTAGENESIS, SITE-DIRECTED; MUTATION; MYRISTIC ACID; PALMITIC ACID; PHOSPHOLIPASE C; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ESTROGEN; S PHASE; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0037371627     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.5.1633-1646.2003     Document Type: Article

References (51)

1. Albanese, C., J. Johnson, G. Watanabe, N. Eklund, D. Vu, A. Arnold, and R. G. Pestell. 1995. Transforming p21 ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270:23589-23597.
2. Alton, G., M. Hasilik, R. Niehues, K. Paneerselvam, J. R. Etchison, F. Fana, and H. H. Freeze. 1998. Direct utilization of mannose for mammalian glycoprotein biosynthesis. Glycobiology 8:285-295.
3. Anderson, R. G. 1998. The caveolae membrane system. Annu. Rev. Biochem. 67:199-225.
4. Aronica, S. M., W. L. Kraus, and B. S. Katzenellenbogen. 1994. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. USA 91:8517-8521.
5. Catoria, G., M. V. Barone, M. Di Domenico, A. Bilancio, D. Ametrano, A. Migliaccio, and F. Auricchio. 1999. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 18:2500-2510.
6. Chambliss, K. L., I. S. Yuhanna, C. Mineo, P. Liu, Z. German, T. S. Sherman, M. E. Mendelsohn, R. G. W. Anderson, and P. W. Shaul. 2000. Estrogen receptor α and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ. Res. 87:e44-e52.
7. Cooper, L. F., J. C. Tiffee, J. P. Griffin, H. Hamano, and Z. Guo. 2000. Estrogen-induced resistance to osteoblast apoptosis is associated with increased hsp27 expression. J. Cell. Physiol. 185:401-407.
8. Donovan, J. C. H., A. Mille, and J. M. Slingerland. 2001. Constitutive MEK/MAPK activation leads to p27kip1 deregulation and antiestrogen resistance in human breast cancer cells. J. Biol. Chem. 276:40888-40895.
9. Duan, R., W. Xie, and S. Safe. 2001. Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1. J. Biol. Chem. 276:11590-11598.
10. Filardo, E. J., J. A. Quinn, K. I. Bland, and R. A. Frackelton, Jr. 2000. Estrogen-induced activation of Erk-1 and Erk-2 requires the G proteincoupled receptor homolog, gpr30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 14:1649-1660.
11. Greene, G., N. Sobel, W. King, and E. Jensen. 1984. Immunochemical studies of estrogen receptors. J. Steroid Biochem. 20:51-56.
12. Holt, A., G. Alton, C. H. Scaman, G. Loppnow, A. Szpacenko, I. Svendsen, and M. M. Palcic. 1998. Identification of the quinone growth cofactor in mammalian semicarbazide-sensitive amine oxidase. Biochemistry 37:4946-4957.
13. Kim, H. P., J. Y. Lee, J. K. Jeong, S. W. Bae, H. K. Lee, and I. Jo. 1999. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae. Biochem. Biophys. Res. Commun. 263:257-262.
14. Kousteni, S., T. Bellido, L. I. Plotkin, C. A. O'Brien, D. L. Bodenner, L. Han, K. Han, G. B. DiGregorio, J. A. Katzenellenbogen, B. S. Katzenellenbogen, P. K. Roberson, R. S. Weinstein, R. L. Jilka, and S. C. Manolagas. 2001. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730.
15. Lavoie, J. N., G. L'Allemain, A. Brunet, R. Muller, and J. Pouyssegur. 1996. Cyclin D1 expression is regulated by the p42/p44 MAPK and negatively by the p38/HOG MAPK pathway. J. Biol. Chem. 271:20608-20616.
16. Le Mellay, V., B. Grosse, and M. Lieberherr. 1997. Phospholipase C beta and membrane action of calcitriol and estradiol. J. Biol. Chem. 272:11902-11907.
17. Levin, E. R. 1999. Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol. Metab. 10:374-376.
18. Lieberherr, M., B. Grosse, M. Kachkache, and S. Balsan. 1993. Cell signaling and estrogens in female rat osteoblasts: a possible involvement of unconventional non-nuclear receptors. J. Bone Min. Res. 8:1365-1376.
19. Lobenhofer, E. K., G. Huper, J. D. Iglehart, and J. R. Marks. 2000. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth Differ. 11:99-110.
20. Lu, M. L., M. C. Schneider, Y. Zhang, and J. P. Richie. 2001. Caveolin-1 interacts with androgen receptor: a positive modulator of androgen receptor mediated transactivation. J. Biol. Chem. 276:13442-13451.
21. Lublin, D. 1992. Glucosyl-phosphatidylinositol anchoring of membrane proteins. Curr. Top. Microbiol. Immunol. 178:142-168.
22. Mandava, M. B. 1988. Plant growth-promoting brassinosteroids. Annu. Rev. Plant Physiol. Plant Mol. Biol. 39:23-52.
23. Marquez, D. C., and R. J. Pietras. 2001. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene 20:5420-5430.
24. Migliaccio, A., M. Di Domenico, G. Castoria, A. de Falco, P. Bontempo, E. Nola, and F. Auricehio. 1996. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15:1292-1300.
25. Morey, A. K., A. Pedram, M. Razandi, B. A. Prins, R.-M. Hu, E. Biesiada, and E. R. Levin. 1997. Estrogen and progesterone inhibit human vascular smooth muscle proliferation. Endocrinology 138:3330-3339.
26. Norfleet, A. M., M. L. Thomas, B. Gametchu, and C. S. Watson. 1999. Estrogen receptor-alpha detected on the plasma membrane of aldehydefixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology 140:3805-3814.
27. Okamoto, T., A. Schlegel, P. E. Scherer, and M. P. Lisanti. 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273:5419-5422.
28. Pedram, A., M. Razandi, and E. R. Levin. 1998. Extracellular regulated kinase/jun kinase cross-talk underlies vascular endothelial cell growth factorinduced endothelial cell proliferation. J. Biol. Chem. 273:26722-26728.
29. Pettersson, K., F. Delaunay, and J. A. Gustafsson. 2000. Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 19:4970-4978.
30. Pietras, R., and C. M. Szego. 1977. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265:69-72.
31. Razandi, M., P. Oh, A. Pedram, J. Schnitzer, and E. R. Levin. 2002. Estrogen receptors associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol. Endocrinol. 16:100-115.
32. Razandi, M., A. Pedram, G. L. Greene, and E. R. Levin. 1999. Cell membrane and nuclear estrogen receptors derive from a single transcript: studies of ERα and ERβ expressed in CHO cells. Mol. Endocrinol. 13:307-319.
33. Razandi, M., A. Pedram, and E. R. Levin. 2000. Estrogen signals to preservation of endothelial cell form and function. J. Biol. Chem. 275:38540-38546.
34. Razandi, M., A. Pedram, and E. R. Levin. 2000. Plasma membrane estrogen receptors signal to anti-apoptosis in breast cancer. Mol. Endocrinol. 14:1434-1447.
35. Resh, M. D. 1996. Regulation of cellular signalling by fatty acid acylation and prenylation of signal transduction proteins. Cell. Signal. 8:403-412.
36. Russell, K. S., M. P. Haynes, D. Sinha, E. Clerisme, and J. R. Bender. 2000. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc. Natl. Acad. Sci. USA 97:5930-5935.
37. Schlegel, A., C. Wang, R. G. Pestell, and M. P. Lisanti. 2001. Ligandindependent activation of oestrogen receptor α by caveolin-1. Biochem. J. 359:203-210.
38. Schnitzer, J. E., D. P. McIntosh, A. M. Dvorak, J. Liu, and P. Oh. 1995. Separation of caveolae from associated microdomains of GPI-anchored proteins. Science 269:1435-1439.
39. 1 cyclins. Cell 73:1059-1065.
40. Simoncini, T., A. Hafezi-Moghadam, D. P. Brazil, K. Ley, W. W. Chin, and J. K. Liao. 2000. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541.
41. Tesarik, J., and C. Mendoza. 1995. Nongenomic effects of 17β-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J. Clin. Endocrinol. Metab. 80:1438-1443.
42. Truss, M., and M. Beato. 1993. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrine Rev. 14:459-479.
43. Valentine, J. E., E. Kalkhoven, R. White, S. Hoare, and M. G. Parker. 2000. Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression. J. Biol. Chem. 275:25322-25329.
44. Wang, Z.-Y., H. Seto, S. Fujioka, S. Yoshida, and J. Chory. 2001. BRI1 is a critical component of a plasma-membrane receptor for plant steroids. Nature 410:380-383.
45. Watters, J. J., J. S. Campbell, M. J. Cunningham, E. G. Krebs, and D. M. Dorsa. 1997. Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138:4030-4033.
46. Watters, J. J., T. Y. Chun, Y. N. Kim, P. J. Bertics, and J. Gorski. 2000. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells. Mol. Endocrinol. 14:1872-1881.
47. Watts, C. K., K. J. Sweeney, A. Warlters, E. A. Musgrove, and R. L. Sutherland. 1994. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells. Breast Canc. Res. Treat. 31:95-105.
48. White, R., J. A. Lees, M. Needham, J. Ham, and M. Parker. 1987. Structural organization and expression of the mouse estrogen receptor. Mol. Endocrinol. 1:735-744.
49. Wise, P. M., D. B. Dubal, M. E. Wislon, S. W. Rau, and M. Bottner. 2001. Neuroprotective effects of estrogen - new insights into mechanisms of action. Endocrinology 142:969-973.
50. i. J. Biol. Chem. 276:27071-27076.
51. Yu, Q., Y. Geng, and P. Sicinski. 2001. Specific protection against breast cancers by cyclin D1 ablation. Nature 411:1017-1021.